"What is the total addressable market?"
The following is from the Gold in Sacks report dated 17 Feb 2021.
"Management quantifies the total addressable opportunity at US$2bn, and whilst PMEhas 40 Visage contracts globally (of which 22 are in the US), we estimate a theoreticaladdressable opportunity in the US exceeding >5k hospitals (albeit likely skewed towards>100 academic facilities in the near term)."
I would add that with the inclusion of AI, and PME's development of other products, the realistic estimate of the addressable market has probably increased since GS wrote the report.
Also, I noted the following in the interview released to the ASX:
"So, whilst we don’t provide forecasts, we have told the market that we anticipate a step-up in transaction volumes in FY22"
And in the webcast, in respect to exam (transaction) revenue, Dr Hupert said the following:
"We are telling the market that we expect this growth to be a step change or a step growth in FY22..."
These guys generally don't say much about future performance, rather, they just quietly deliver.
So a mention of a step change in exam revenue for FY22 gets my attention.
Cheers
- Forums
- ASX - By Stock
- Ann: Interview with CEO - Full year results
"What is the total addressable market?"The following is from the...
Featured News
Add PME (ASX) to my watchlist
(20min delay)
|
|||||
Last
$133.28 |
Change
2.395(1.83%) |
Mkt cap ! $13.87B |
Open | High | Low | Value | Volume |
$131.00 | $133.87 | $130.70 | $3.498M | 26.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 113 | $133.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$133.31 | 31 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 42 | 133.210 |
5 | 41 | 133.200 |
3 | 27 | 133.190 |
3 | 33 | 133.180 |
4 | 39 | 133.170 |
Price($) | Vol. | No. |
---|---|---|
133.320 | 11 | 1 |
133.360 | 36 | 2 |
133.370 | 26 | 2 |
133.380 | 18 | 2 |
133.400 | 20 | 1 |
Last trade - 10.52am 08/07/2024 (20 minute delay) ? |
Featured News
PME (ASX) Chart |